Repligen Receives FDA Fast Track Designation For RG1068 For Pancreatic Imaging (Medical News Today)
Repligen Corporation (Nasdaq: RGEN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the development program for RG1068, synthetic human secretin, to improve the assessment of pancreatic duct structures by magnetic resonance imaging (MRI).

Email This | Print This (The Daily Record)
REGULATORY AFFAIRS/REGULATORY COMPLIANCE ASSOCIATE Zimmer Orthopaedic Surgical Products is a leading supplier of medical products and part of the Zimmer family. We have a challenging opportunity in our Regulatory Department.

DMR begins shoreline surveys (Boothbay Register)
Representative Bruce MacDonald promised local shell fishermen that he would continue to pressure the Maine Department of Marine Resources (DMR) to complete the shoreline surveys needed to reopen clams flats in the Sheepscot River.